CV Lattes
ResearcherID
ORCID
Universidade Federal de São Paulo (UNIFESP). Campus Diadema. Instituto de Ciências Ambientais, Químicas e Farmacêuticas (ICAQF) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Dorival Mendes Rodrigues Junior in research grants and scholarships supported by FAPESP.
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
The head and neck cancer has a worldwide incidence of 500,000 cases per year, and the squamous cell carcinoma (HNSCC) is the most common variant. Previous data have shown that induction chemotherapy (IC) with cisplatin and paclitaxel followed by chemoradiotherapy (CRT) based on cisplatin is safe, well tolerated and provides a higher overall survival for the patients with locally advanced …
Multiple myeloma (MM) is a B cells malignancy, described as incurable, characterized by multiple organ failure as result of bone marrow infiltration by malignant cells and systemic damage circulating monoclonal protein. Despite considerable progress in understanding the biology of MM, the molecular basis of this disease remains open to debate. The identification of new molecular markers c…
Approximately 30% of patients with locally advanced head and neck squamous cell carcinoma (HNSCC) (stage III -IV) treated with cisplatin-based chemoradiotherapy (CRT) have incomplete response to the treatment and there is no biomarker able to prospectively segregate these patients from those who respond to the treatment. It had been shown that TGF² is a regulator of radiation therapy and …
| 2 / 2 | Completed scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 3 / 3 | All Scholarships |
| Associated processes | |